Definitive Healthcare prices IPO at $27, above range
Definitive Healthcare Corp. DH, said late Tuesday it priced its initial public offering at $27 a share, selling more than 15 million shares above an expected range between $21 and $24 a share.
From the Equity Insider archive. This article dates from Sep 15, 2021 and is preserved as first published.
Definitive Healthcare Corp. DH, said late Tuesday it priced its initial public offering at $27 a share, selling more than 15 million shares above an expected range between $21 and $24 a share.
DH, said late Tuesday it priced its initial public offering at $27 a share, selling more than 15 million shares above an expected range between $21 and $24 a share.
The shares are slated to begin trading on the Nasdaq under the ticker symbol DH on Wednesday. Underwriters including Goldman Sachs and JPMorgan have a 30-day option to buy an additional 2.3 million shares at the IPO price. Definitive provides a healthcare commercial intelligence and analytics platform and its IPO is part of a busy week for launches, with 2021 poised to be the biggest year ever for IPO proceeds.
